The longitudinal follow-up of a newly proposed OCTA imaging finding (SSPiM) and the importance of it as a new biomarker for treatment response in diabetic macular edema.
Gülsüm GençÖzge YanıkSibel DemirelFigen ŞermetEmin OzmertPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)
SSPiM is a finding seen in approximately one-third of DME patients and may adversely affect the response to the treatment.